SMITH & NEPHEW
 
Notifications
Clear all

SN - SMITH & NEPHEW - Share Chat

Price: Market Cap.: (Ā£m)

Smith & Nephew plc is a global medical technology company headquartered in the UK and a constituent of the FTSE 100 index. It designs, manufactures, and markets a diverse portfolio of products across three main franchises: Orthopaedics (covering hip and knee implants, trauma, and extremities), Advanced Wound Management (including chronic and acute wound care solutions), and Sports Medicine & ENT (focusing on surgical techniques for joint repair and minimally invasive procedures).

Recognised as a leader in its specialist markets, Smith & Nephew is committed to innovation, investing significantly in research and development to enhance patient outcomes and clinician efficiency. The company serves healthcare providers worldwide, navigating a competitive landscape with a focus on product differentiation, market access, and operational efficiency to drive sustainable growth.

Posts: 1675
Topic starter
(@mrmultibagger)
Member
Joined: 3 years ago

Chat about SMITH & NEPHEW


1 Reply
Posts: 1675
Topic starter
(@mrmultibagger)
Member
Joined: 3 years ago

Smith & Nephew (SNN): A med-tech giant with a fascinating journey. What's your current take on its performance, valuation, and future prospects? Any recent RNS catches your eye or concerns you? Let's discuss!


Reply

Scroll to Top